Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Splenic Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor)
2001
Inflammatory Myofibroblastic Tumor (Inflammatory Fibrosarcoma) of the Bone
2000
Nasopharyngeal carcinoma
2005 Standout
DNA methylation and the Epstein–Barr virus
1999
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Inflammatory pseudotumor of lymph node and spleen: An entity biologically distinct from inflammatory myofibroblastic tumor
2001
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
2000 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
The chemopreventive compound curcumin is an efficient inhibitor of Epstein‐Barr virus BZLF1 transcription in Raji DR‐LUC cells*
2002
Epstein–Barr virus in the pathogenesis of NPC
2002
Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B
2000
Quantitative Analysis of Epstein‐Barr Virus DNA in Plasma and Serum
2001
Entecavir Therapy for Adefovir-Resistant Hepatitis B Virus Infection in Kidney and Liver Allograft Recipients
2008
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Viral Infection in the Renal Transplant Recipient
2005
HBV GENOTYPIC RESISTANCE TO LAMIVUDINE IN KIDNEY RECIPIENTS AND HEMODIALYZED PATIENTS
2000
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy
2003
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Anaplastic Lymphoma Kinase Expression in Inflammatory Pseudotumors
2001
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Inflammatory Bowel Disease
2009 Standout
Chronic hepatitis B treatment with lamivudine in kidney transplant patients
2000
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Management of chronic viral hepatitis before and after renal transplantation
2002
Lamivudine Therapy in Kidney Allograft Recipients Who Are Seropositive for Hepatitis B Surface Antigen
2006
Cytokeratin-Positive Malignant Tumors With Reticulum Cell Morphology
2000
Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs
2009
Natural and iatrogenic variation in hepatitis B virus
1999
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
2004
Calcifying Fibrous Pseudotumor versus Inflammatory Myofibroblastic Tumor: A Histological and Immunohistochemical Comparison
2001
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
2006
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Nasopharyngeal carcinoma
2015 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine
2000
Chronic hepatitis B
2007 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Chronic hepatitis B: Update 2009 #
2009 Standout
One‐Pot Functionalization of Graphene with Porphyrin through Cycloaddition Reactions
2011 StandoutNobel
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
2005
Epstein–Barr virus: 40 years on
2004 Standout
Treatment of chronic hepatitis B with lamivudine in renal allograft recipients
2000
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
2005
The Role of Epstein-Barr Virus in Neoplastic Transformation
2001
Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus‐Infected Patients Following Development of Resistance to or Withdrawal of Lamivudine
1999
Outcome of renal transplantation in hepatitis B surface antigen‐positive patients after introduction of lamivudine†
2001
TWELVE MONTHS OF LAMIVUDINE TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS12
2000
Inflammatory Pseudotumor-Like Follicular Dendritic Cell Tumor
2001
Infectious agents and lymphoma development: molecular and clinical aspects
2009
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Lamivudine in recurrent hepatitis B after renal transplantation
2001
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
2005
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
2002
So‐called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells?
2005
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Prospective Study on Lamivudine-Resistant Hepatitis B in Renal Allograft Recipients
2004
Inflammatory Pseudotumor of the Spleen Associated With a Clonal Epstein-Barr Virus Genome: Case Report and Review of the Literature
2003
Infection in Solid-Organ Transplant Recipients
2007 Standout
JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis C
2005
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B
2004
A novel form of Epstein-Barr virus latency in normal B cells in vivo
1995 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients
2001
RESULTS ON PREEMPTIVE OR PROPHYLACTIC TREATMENT OF LAMIVUDINE IN HBsAg (+) RENAL ALLOGRAFT RECIPIENTS: COMPARISON WITH SALVAGE TREATMENT AFTER HEPATIC DYSFUNCTION WITH HBV RECURRENCE
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Is Calcifying Fibrous Pseudotumor a Late Sclerosing Stage of Inflammatory Myofibroblastic Tumor?
1999
Inflammatory Myofibroblastic Tumor of Bone
1997
Effects of long-term lamivudine therapy in renal-transplant patients
2004
Head and Neck Cancer
2001 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2
2005
Epstein–Barr Virus Infection
2000 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
TREATMENT OF CHRONIC HEPATITIS B WITH LAMIVUDINE IN RENAL TRANSPLANT RECIPIENTS1
1998
Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
2002
Pregnancy-Associated Depression of Cell-Mediated Immunity
1984
Epstein-Barr virus infection and human malignancies.
2001
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
2000
Long-Term Lamivudine Monotherapy in Renal-Transplant Recipients with Hepatitis-B-Related Cirrhosis
2005
Long-Term Outcome of Renal Transplant Recipients With Chronic Hepatitis B Infection—Impact of Antiviral Treatments
2010
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Compartmentalization and Transmission of Multiple Epstein-Barr Virus Strains in Asymptomatic Carriers
2003
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
2005
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
2014
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Inflammatory Pseudotumor of the Spleen Associated With a Clonal Epstein-Barr Virus Genome
2003
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Lamivudine therapy for hepatitis B in renal transplantation
2002
Influenza Vaccination of Health-Care Personnel: Recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP)
2006
Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis
2007 Standout
Electrochemiluminescence (ECL)
2004 Standout
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
1999
Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients
2005
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR
1999
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.
1988
Epstein‐Barr virus infection and human malignancies
2001
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
2007
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of J Icart being referenced
Prevalence of Antibodies to Hepatitis C Virus and Correlation with Liver Disease in Renal Transplant Patients
1997
Measurement by the polymerase chain reaction of the Epstein‐Barr virus load in infectious mononucleosis and AIDS‐related non‐Hodgkin's lymphomas
1995
JC Virus Genotypes in France: Molecular Epidemiology and Potential Significance for Progressive Multifocal Leukoencephalopathy
2001
Inflammatory Pseudotumor of the Liver
1996
NOSOCOMIAL OUTBREAK OF INFLUENZA VIRUS A (H3N2) INFECTION IN A SOLID ORGAN TRANSPLANT DEPARTMENT
2001
EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATION
1997
High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease
1999
Prevalence of JC Virus Viraemia in HIV-Infected Patients with or Without Neurological Disorders: A Prospective Study
1998
Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients
2001
In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different epstein-barr virus strains
2001
CMV Prophylaxis in High-Risk Renal Transplant Patients (D+/R-) by Acγclovir with or without Hyperimmune (CMV) Immunoglobulins: A Prospective Study
1997
Cytomegalovirus (CMV) prophylaxis by acyclovir in pre-transplant CMV-positive renal transplant recipients
1994
Epstein‐barr virus serology in bone marrow transplantations: A one‐year retrospective study with detection of EBV IgM‐VCA‐specific antibodies
1986
Prospective study of Epstein Barr virus (EBV) infection during pregnancy.
1981